ArkVax
PrivateLast Round
Seed
Dec 5, 2022
Total Funding Raised
$13,000
Company Overview
ArkVax is a biotechnology company that develops recombinant glycoconjugate vaccines for animals through glycoengineering.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArkVax Comparables
Compare ArkVax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Malcisbo AG | 85% | |
| Scaffold Biotech | 77% | |
| The Vaccine Group | 77% |
ArkVax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 5, 2022 | ||||
| Accelerator | Sep 21, 2020 |
ArkVax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Planet Capital Regional | Seed |
| Start Codon | Seed |
| Accelerate@Babraham | Accelerator |
| UK Innovation & Science Seed Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2020
$13K raised from Accelerate@Babraham.
ArkVax Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ArkVax's valuation, stock price, and market status.
Is ArkVax a public or private company?
ArkVax is a private company.
What is the current stock price of ArkVax?
ArkVax is a private company, so its shares have no public market price. Caplight tracks ArkVax's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ArkVax worth (valuation)?
Valuation information for ArkVax is not publicly available.
Can I buy ArkVax stock?
ArkVax shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ArkVax's last funding round?
ArkVax's most recent funding round was Seed on December 5, 2022.
Who are the main investors in ArkVax?
Key investors in ArkVax include Start Codon.
Will ArkVax IPO soon?
No public IPO plans have been announced for ArkVax.
How can I track ArkVax secondary market activity?
Caplight tracks bids, offers, and trades in ArkVax's shares on secondary markets.